Press Releases

Press Releases

    Date Title View
    11/22/19
    Summary ToggleHorizon Therapeutics plc Opens New Manufacturing and R&D Facility in South San Francisco
    PDF Version
    11/21/19
    Summary ToggleHorizon Therapeutics plc Launches New Online Community Connecting People Living with Thyroid Eye Disease and Urging them to “Listen to Your Eyes”
    PDF Version
    11/14/19
    Summary ToggleFORTUNE and Great Place to Work® Name Horizon Therapeutics plc to Best Workplaces for Parents List
    PDF Version
    11/13/19
    Summary ToggleHorizon Therapeutics plc to Participate in Upcoming Investor Conferences
    PDF Version
    11/11/19
    Summary ToggleData from Uncontrolled Gout Case Series Supports Immunomodulation with KRYSTEXXA® (pegloticase injection) Strategy to Optimize Treatment Outcomes
    PDF Version
    11/08/19
    Summary ToggleThe Chicago Tribune Names Horizon Therapeutics plc a 2019 Top Workplace
    PDF Version
    11/06/19
    Summary ToggleHorizon Therapeutics plc Reports Strong Third-Quarter 2019 Results
    11/05/19
    Summary ToggleHorizon Therapeutics plc Brings Gout-Kidney Link into Focus during American Society of Nephrology (ASN) Kidney Week 2019
    PDF Version
    11/04/19
    Summary ToggleClinical Study Data Highlighting the Impact of Teprotumumab in Patients With Active Thyroid Eye Disease to Be Presented During ACR Annual Meeting
    PDF Version
    11/04/19
    Summary ToggleNew Evidence on the Burden of Gout to be Featured in Data Presentations at Upcoming ACR Annual Meeting
    PDF Version
    Displaying 21 - 30 of 495 results